MedPath

CENMICIN 100/50 mg/ml Solution For Injection

Registration Number: MAL22076047HA

Approved
Approval ID

9a3257ea7678debd

Registration Number

MAL22076047HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

100 mlAvailable
Package Size: 100 ml
Status: NPRA Approved
250 mlAvailable
Package Size: 250 ml
Status: NPRA Approved
500 mlAvailable
Package Size: 500 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

SPECTINOMYCIN SULFATE TETRAHYDRATEActive
Monograph: spectinomycin sulfate tetrahydrate
Lincomycin HydrochlorideActive
Monograph: 林可霉素

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CENMICIN 100/50 mg/ml Solution For Injection - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform